BeiGene, Ltd.
ONC
$230.98
$2.841.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.19B | 1.03B | 929.17M | 751.65M | 643.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.19B | 1.03B | 929.17M | 751.65M | 643.04M |
| Cost of Revenue | 173.02M | 171.56M | 138.13M | 124.94M | 111.92M |
| Gross Profit | 1.02B | 854.56M | 791.03M | 626.72M | 531.11M |
| SG&A Expenses | 531.28M | 472.48M | 443.73M | 427.43M | 404.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.26M | 1.28M | -- | -- | 23.87M |
| Total Operating Expenses | 1.26B | 1.17B | 1.04B | 1.01B | 1.02B |
| Operating Income | -75.01M | -142.60M | -107.16M | -261.35M | -381.45M |
| Income Before Tax | -65.63M | -134.22M | -105.92M | -243.43M | -320.49M |
| Income Tax Expenses | 74.06M | 16.70M | 14.49M | 7.72M | 14.31M |
| Earnings from Continuing Operations | -139.70M | -150.92M | -120.41M | -251.15M | -334.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -139.70M | -150.92M | -120.41M | -251.15M | -334.79M |
| EBIT | -75.01M | -142.60M | -107.16M | -261.35M | -381.45M |
| EBITDA | -33.25M | -119.32M | -83.41M | -237.24M | -358.75M |
| EPS Basic | -17.09 | -18.69 | -14.95 | -31.31 | -41.82 |
| Normalized Basic EPS | -0.38 | -0.77 | -0.63 | -1.45 | -4.11 |
| EPS Diluted | -17.09 | -18.69 | -14.95 | -31.31 | -41.82 |
| Normalized Diluted EPS | -0.38 | -0.77 | -0.63 | -1.45 | -4.11 |
| Average Basic Shares Outstanding | 106.26M | 104.97M | 104.70M | 104.27M | 104.08M |
| Average Diluted Shares Outstanding | 8.17M | 8.07M | 8.05M | 8.02M | 8.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -9.60% | -- | -- | -- |